Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 216

1.

Beta-blockers in congestive heart failure. A Bayesian meta-analysis.

Brophy JM, Joseph L, Rouleau JL.

Ann Intern Med. 2001 Apr 3;134(7):550-60.

PMID:
11281737
3.

MERIT-HF mortality and morbidity data.

Hjalmarson A, Fagerberg B.

Basic Res Cardiol. 2000;95 Suppl 1:I98-103. Review.

PMID:
11192362
4.

Beta-blocker therapy for congestive heart failure: a systemic overview and critical appraisal of the published trials.

Avezum A, Tsuyuki RT, Pogue J, Yusuf S.

Can J Cardiol. 1998 Aug;14(8):1045-53. Review.

PMID:
9738164
6.

Meta-analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure.

McAlister FA, Wiebe N, Ezekowitz JA, Leung AA, Armstrong PW.

Ann Intern Med. 2009 Jun 2;150(11):784-94.

PMID:
19487713
7.

Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials.

Lechat P, Packer M, Chalon S, Cucherat M, Arab T, Boissel JP.

Circulation. 1998 Sep 22;98(12):1184-91.

8.

A comparative analysis of the results from 4 trials of beta-blocker therapy for heart failure: BEST, CIBIS-II, MERIT-HF, and COPERNICUS.

Domanski MJ, Krause-Steinrauf H, Massie BM, Deedwania P, Follmann D, Kovar D, Murray D, Oren R, Rosenberg Y, Young J, Zile M, Eichhorn E; BEST Investigators.

J Card Fail. 2003 Oct;9(5):354-63. Review.

PMID:
14583895
9.

Effects of ACE inhibitors or beta-blockers in patients treated with the fixed-dose combination of isosorbide dinitrate/hydralazine in the African-American Heart Failure Trial.

Ghali JK, Tam SW, Ferdinand KC, Lindenfeld J, Sabolinski ML, Taylor AL, Worcel M, Curry CL, Cohn JN; A-HeFT Investigators.

Am J Cardiovasc Drugs. 2007;7(5):373-80.

PMID:
18041162
10.
11.

Beta-blockers: a new therapy in congestive heart failure.

Meghani SH, Becker D.

Am J Crit Care. 2001 Nov;10(6):417-27; quiz 428-9. Review.

PMID:
11688609
12.

Meta-analysis: angiotensin-receptor blockers in chronic heart failure and high-risk acute myocardial infarction.

Lee VC, Rhew DC, Dylan M, Badamgarav E, Braunstein GD, Weingarten SR.

Ann Intern Med. 2004 Nov 2;141(9):693-704. Erratum in: Ann Intern Med. 2005 Mar 1;42(5):391. Dosage error in article text.

PMID:
15520426
13.

Beta-adrenergic blocking agents in heart failure: benefits of vasodilating and non-vasodilating agents according to patients' characteristics: a meta-analysis of clinical trials.

Bonet S, Agustí A, Arnau JM, Vidal X, Diogène E, Galve E, Laporte JR.

Arch Intern Med. 2000 Mar 13;160(5):621-7.

PMID:
10724047
14.

Beta-blockers and heart failure: meta-analysis of mortality trials.

Cleophas TJ, Zwinderman AH.

Int J Clin Pharmacol Ther. 2001 Sep;39(9):383-8.

PMID:
11563684
16.
17.

Economic effects of beta-blocker therapy in patients with heart failure.

Cowper PA, DeLong ER, Whellan DJ, Allen LaPointe NM, Califf RM.

Am J Med. 2004 Jan 15;116(2):104-11.

PMID:
14715324
18.

Use of beta-blockers in chronic congestive heart failure.

Mahanonda N, Samranthin M, Panyarachun S.

J Med Assoc Thai. 2000 Oct;83(10):1240-7. Review.

PMID:
11143491
19.

Systematic review: cardiac resynchronization in patients with symptomatic heart failure.

McAlister FA, Ezekowitz JA, Wiebe N, Rowe B, Spooner C, Crumley E, Hartling L, Klassen T, Abraham W.

Ann Intern Med. 2004 Sep 7;141(5):381-90. Epub 2004 Aug 16. Review. Erratum in: Ann Intern Med. 2005 Feb 15;142(4):311.

PMID:
15353430
20.

Beta-blocker treatment in heart failure.

Bouzamondo A, Hulot JS, Sanchez P, Cucherat M, Lechat P.

Fundam Clin Pharmacol. 2001 Apr;15(2):95-109. Review.

PMID:
11468019

Supplemental Content

Support Center